Compounds > ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination
Page last updated: 2024-09-04

ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and kainic acid

ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination has been researched along with kainic acid in 1 studies

Compound Research Comparison

Studies
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)		Trials
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)		Recent Studies (post-2010)
(ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination)		Studies
(kainic acid)		Trials
(kainic acid)		Recent Studies (post-2010) (kainic acid)
24509,54031,775

Protein Interaction Comparison

ProteinTaxonomyketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination (IC50)kainic acid (IC50)
Glutamate receptor 1Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 2Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 3Rattus norvegicus (Norway rat)4.2857
Glutamate receptor 4Rattus norvegicus (Norway rat)4.2857
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)0.0126
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 3Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 4Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 5Homo sapiens (human)0.077
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)0.0126

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Khan, FA; Lian, XY; Stringer, JL1

Other Studies

1 other study(ies) available for ketobemidone, n,n-dimethyl-3,3-diphenyl-1-methylallylamine drug combination and kainic acid

ArticleYear
Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2007, Oct-31, Volume: 27, Issue:44

    Topics: Acute Disease; Allylamine; Analysis of Variance; Animals; Anticonvulsants; Behavior, Animal; Deoxyglucose; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Combinations; Fructosediphosphates; Kainic Acid; Male; Meperidine; Models, Chemical; Pilocarpine; Rats; Rats, Sprague-Dawley; Seizures; Valproic Acid

2007